2m 2m 2m 2m 2m 2m 2m
Becton Dickinson (BDX)
NYSE
$143.95+$3.23 (+2.30%)
Price as of Jun 23, 2026 5:52 PM EDT- $38.8BMarket Cap
- -15.06%1-Year Change
- Medical Instruments & SuppliesIndustry
Becton Dickinson (BDX)
$143.95+$3.23 (+2.30%)
Annual
Quarterly
09/30/2025 | 09/30/2024 | 09/30/2023 | 09/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 21.8B +8.24% | 20.2B +4.16% | 19.4B +2.66% | 18.9B -6.81% | |
Cost of Revenue | 11.9B +7.80% | 11.1B -1.33% | 11.2B +7.78% | 10.4B -3.96% | |
Gross Profit | 9.9B +8.77% | 9.1B +11.69% | 8.2B -3.62% | 8.5B -10.08% | |
Sales and Marketing Expense | 5.3B +8.67% | 4.9B +2.92% | 4.7B +0.21% | 4.7B -3.25% | |
Research and Development Expense | -1.3B +6.30% | -1.2B -3.80% | -1.2B -1.51% | -1.3B -6.20% | |
Depreciation and Amortization Expense | 2.5B +7.70% | 2.3B -0.09% | 2.3B +2.65% | 2.2B -1.94% | |
Total Operating Expenses | 19.3B +8.33% | 17.8B +3.01% | 17.3B +4.06% | 16.6B -4.93% | |
Operating Profit | 2.6B +7.59% | 2.4B +13.55% | 2.1B -7.49% | 2.3B -18.47% | |
Interest Income | 38.0M -76.69% | 163.0M +232.65% | 49.0M +206.25% | 16.0M +77.78% | |
Interest Expense | -613.0M +16.10% | -528.0M +16.81% | -452.0M +13.57% | -398.0M -15.14% | |
Interest Income and Expense and Net | -575.0M +57.53% | -365.0M -9.43% | -403.0M +5.50% | -382.0M -16.96% | |
Total Nonoperating Income and Expense | -123.0M +339.29% | -28.0M -39.13% | -46.0M -60.68% | -117.0M +20.62% | |
Income before Taxes | 1.9B -6.18% | 2.0B +20.64% | 1.7B -6.79% | 1.8B -20.47% | |
Income Taxes | 203.0M -32.33% | 300.0M +127.27% | 132.0M -10.81% | 148.0M -1.33% | |
Extraordinary Items | 30.0M -63.86% | 83.0M +53.70% | 54.0M +390.91% | 11.0M -77.55% | |
Net Income | 1.7B -1.58% | 1.7B +14.89% | 1.5B -16.58% | 1.8B -14.96% | |
Net Income from Continuing Operations Applicable to Common | 1.7B -1.58% | 1.7B +11.44% | 1.5B -6.42% | 1.6B -18.33% | |
Basic EPS and Net Income | 5.83 -0.85% | 5.88 +18.31% | 4.97 -16.19% | 5.93 -14.31% | |
Diluted EPS and Net Income | 5.82 -0.68% | 5.86 +18.62% | 4.94 -15.99% | 5.88 -14.16% | |
Basic Weighted Average Shares | 287.6M -0.73% | 289.8M +1.22% | 286.3M +0.45% | 285.0M -1.48% | |
Diluted Weighted Average Shares | 288.5M -0.86% | 291.0M +0.91% | 288.4M +0.36% | 287.4M -1.62% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 641.0M -62.67% | 1.7B +21.26% | 1.4B +40.76% | 1.0B -55.94% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 641.0M -62.67% | 1.7B +21.26% | 1.4B +40.76% | 1.0B -55.94% | |
Total Current Assets | 9.3B -11.59% | 10.5B +20.65% | 8.7B +6.57% | 8.1B -7.89% | |
Accumulated Depreciation | 8.1B +7.40% | 7.6B +7.63% | 7.0B +9.67% | 6.4B -2.24% | |
Property and Plant and Equipment and Net | 7.0B +2.58% | 6.8B +4.03% | 6.6B +9.07% | 6.0B -5.96% | |
Total Long-Term Assets | 3.1B +16.86% | 2.6B +25.84% | 2.1B +12.45% | 1.8B -5.33% | |
Total Assets | 55.3B -3.42% | 57.3B +8.54% | 52.8B -0.29% | 52.9B -1.73% | |
Income Taxes Payable | 329.0M +95.83% | 168.0M +20.86% | 139.0M -11.46% | 157.0M -10.80% | |
Total Short-Term Debt | 1.6B -28.11% | 2.2B +90.18% | 1.1B -47.64% | 2.2B +335.80% | |
Total Current Liabilities | 8.3B -7.18% | 9.0B +34.86% | 6.6B -14.98% | 7.8B +17.88% | |
Total Long-Term Debt | 17.6B -1.78% | 17.9B +21.73% | 14.7B +6.14% | 13.9B -18.84% | |
Total Long-Term Liabilities | 2.9B -17.57% | 3.6B -22.35% | 4.6B -9.30% | 5.1B -3.31% | |
Total Liabilities | 8.3B -7.18% | 9.0B +34.86% | 6.6B -14.98% | 7.8B +17.88% | |
Retained Earnings | 16.6B +2.99% | 16.1B +3.89% | 15.5B +2.49% | 15.2B +9.63% | |
Total Stockholders Equity | 25.4B -1.93% | 25.9B +0.36% | 25.8B +2.03% | 25.3B +6.78% | |
Total Shares Outstanding | 370.6M 0.00% | 370.6M 0.00% | 370.6M +1.63% | 364.6M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 3.4B -9.69% | 3.8B +27.07% | 3.0B +13.48% | 2.6B -43.32% | |
Capital Expenditures | 760.0M +4.83% | 725.0M -17.05% | 874.0M -10.17% | 973.0M -20.96% | |
Cash from Investing Activities | -818.0M -85.17% | -5.5B +670.11% | -716.0M -77.84% | -3.2B +71.86% | |
Dividends Paid | 1.2B +8.73% | 1.1B -1.26% | 1.1B +2.96% | 1.1B +3.24% | |
Cash from Financing Activities | -3.6B -273.31% | 2.1B +206.70% | -2.0B +230.96% | -591.0M -82.12% | |
Financials Ratio | |||||
Gross Margin | 45.44% +0.49% | 45.22% +7.23% | 42.17% -6.12% | 44.92% -3.51% | |
Operating Margin | 11.81% -0.60% | 11.88% +9.01% | 10.90% -9.89% | 12.09% -12.52% | |
Return on Assets | 2.98% -3.81% | 3.10% +10.35% | 2.81% -15.73% | 3.33% -14.10% | |
Return on Equity | 6.54% -0.80% | 6.60% +13.54% | 5.81% -20.04% | 7.27% -17.60% | |
Revenue Growth | 8.24% +97.97% | 4.16% +56.40% | 2.66% +139.09% | -6.81% -137.21% | |
Current Ratio | 1.11 -4.75% | 1.17 -10.53% | 1.31 +25.35% | 1.04 -21.86% | |
Cash Ratio | 0.08 -59.78% | 0.19 -10.08% | 0.21 +65.53% | 0.13 -62.62% | |
Debt-to-Equity Ratio | 0.76 -2.73% | 0.78 +26.17% | 0.62 -3.12% | 0.64 -14.57% | |
Debt-to-Assets Ratio | 0.35 -1.23% | 0.35 +16.65% | 0.30 -0.86% | 0.30 -7.16% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow